Cite
HARVARD Citation
Kalimutho, M. et al. (2018). CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO molecular medicine. 10 (9), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kalimutho, M. et al. (2018). CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO molecular medicine. 10 (9), p. n/a. [Online].